bf/NASDAQ:HRTX_icon.jpeg

COM:HERONTX

Heron Therapeutics

  • Stock

Last Close

1.06

22/11 21:00

Market Cap

457.99M

Beta: -

Volume Today

1.33M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-55.28M
-
-76.37M
38.14%
-97.59M
27.79%
-173.14M
77.42%
-197.48M
14.06%
-178.84M
9.44%
-204.75M
14.49%
-227.28M
11.00%
-220.68M
2.90%
-182.02M
17.52%
-110.56M
39.26%
depreciation and amortization
333K
-
578K
73.57%
734K
26.99%
1.10M
49.73%
1.53M
39.31%
1.51M
1.18%
2.04M
35.10%
2.85M
39.29%
3.02M
6.11%
2.89M
4.37%
2.90M
0.35%
deferred income tax
922K
-
-29K
103.15%
283K
1,075.86%
-239K
184.45%
-3.31M
1,285.36%
-3.57M
7.79%
972K
127.23%
1.63M
67.90%
-4.39M
-
stock based compensation
10.89M
-
8.07M
25.92%
14.36M
78.01%
25.96M
80.75%
30.54M
17.65%
33.37M
9.26%
51.41M
54.08%
50.22M
2.32%
46.85M
6.70%
42.98M
8.26%
32.85M
23.56%
change in working capital
2.76M
-
5.95M
115.09%
3.38M
43.21%
11.02M
226.39%
-5.42M
149.18%
-45.42M
738.24%
29.23M
164.36%
-13.01M
144.50%
-35.08M
169.67%
-10.51M
70.05%
16.79M
259.81%
accounts receivables
-1.96M
-
-39.91M
1,936.43%
-22.78M
42.93%
24.77M
208.76%
-1.97M
107.96%
6.35M
422.22%
-16.55M
360.59%
-8.09M
51.13%
inventory
-5.34M
-
-4.77M
10.71%
-29.12M
510.78%
14.06M
148.29%
-16.94M
220.43%
-6.48M
61.76%
-6.19M
4.42%
12.46M
301.31%
accounts payables
-426K
-
1.28M
401.64%
751K
41.56%
3.51M
367.91%
11.96M
240.21%
-1.91M
115.94%
-14.11M
640.03%
-2.23M
84.17%
3.28M
246.80%
-578K
117.63%
15K
102.60%
other working capital
3.19M
-
4.66M
46.08%
2.63M
43.67%
14.80M
464.00%
27.31M
84.45%
8.38M
69.31%
4.50M
46.30%
8.13M
80.69%
-38.23M
570.07%
12.81M
133.51%
12.40M
3.22%
other non cash items
533K
-
573K
7.50%
624K
8.90%
689K
10.42%
773K
12.19%
890K
15.14%
1.05M
17.98%
1.43M
36.10%
904K
36.74%
-251K
127.77%
3.62M
1,541.04%
net cash provided by operating activities
-40.76M
-
-60.28M
47.88%
-78.53M
30.26%
-134.10M
70.77%
-170.30M
27.00%
-191.81M
12.63%
-124.58M
35.05%
-184.82M
48.35%
-203.35M
10.03%
-146.91M
27.76%
-58.79M
59.98%
investments in property plant and equipment
-1.69M
-
-1.44M
14.66%
-1.09M
24.48%
-3.13M
188.67%
-2.55M
18.56%
-9.17M
259.22%
-7.15M
21.99%
-6.81M
4.77%
-3.02M
55.64%
-1.82M
39.61%
-1.54M
15.34%
acquisitions net
-25K
-
-215.77M
862,972.00%
32K
100.01%
227K
609.38%
13K
94.27%
purchases of investments
-56.12M
-
-43.32M
22.80%
-121.57M
180.65%
-497.10M
308.90%
-477.04M
4.04%
-134.01M
71.91%
-129.22M
3.57%
-145.68M
12.74%
-87.66M
39.83%
sales maturities of investments
61.33M
-
131.78M
114.88%
227.70M
72.78%
462.41M
103.08%
349.77M
24.36%
164.94M
52.84%
143.96M
12.72%
107.19M
25.54%
other investing activites
241K
-
78K
-
25K
67.95%
25K
0%
215.77M
862,972.00%
net cash used for investing activites
-1.69M
-
-1.44M
14.66%
-56.96M
3,861.06%
14.88M
126.12%
7.74M
47.98%
-278.55M
3,699.77%
-21.78M
92.18%
208.96M
1,059.26%
32.73M
84.34%
-3.32M
110.16%
18.00M
641.37%
debt repayment
-25M
-
-25M
0%
-26K
-
-148.96M
572,834.62%
-24.35M
-
common stock issued
57.80M
-
58.92M
1.93%
128.20M
117.60%
306.28M
-
363.13M
18.56%
162.15M
55.35%
9.08M
94.40%
7.07M
22.18%
75.14M
963.62%
29.76M
60.40%
common stock repurchased
dividends paid
other financing activites
3.43M
-
3.19M
6.86%
9.79M
206.77%
57.45M
486.75%
12.45M
78.33%
19.48M
56.44%
24.27M
24.61%
52K
99.79%
297.93M
572,834.62%
-86K
100.03%
48.70M
56,727.91%
net cash used provided by financing activities
61.23M
-
62.11M
1.44%
137.99M
122.18%
57.45M
58.36%
293.73M
411.24%
357.61M
21.75%
186.43M
47.87%
9.11M
95.12%
156.03M
1,613.65%
75.06M
51.89%
54.11M
27.91%
effect of forex changes on cash
net change in cash
18.78M
-
388K
97.93%
2.50M
545.62%
-61.77M
2,565.71%
131.17M
312.36%
-112.75M
185.96%
40.06M
135.53%
33.24M
17.03%
-14.60M
143.91%
-75.18M
415.02%
13.31M
117.71%
cash at beginning of period
53.51M
-
72.29M
35.10%
72.67M
0.54%
75.18M
3.45%
13.41M
82.16%
144.58M
977.85%
31.84M
77.98%
71.90M
125.84%
105.14M
46.23%
90.54M
13.88%
15.36M
83.03%
cash at end of period
72.29M
-
72.67M
0.54%
75.18M
3.45%
13.41M
82.16%
144.58M
977.85%
31.84M
77.98%
71.90M
125.84%
105.14M
46.23%
90.54M
13.88%
15.36M
83.03%
28.68M
86.65%
operating cash flow
-40.76M
-
-60.28M
47.88%
-78.53M
30.26%
-134.10M
70.77%
-170.30M
27.00%
-191.81M
12.63%
-124.58M
35.05%
-184.82M
48.35%
-203.35M
10.03%
-146.91M
27.76%
-58.79M
59.98%
capital expenditure
-1.69M
-
-1.44M
14.66%
-1.09M
24.48%
-3.13M
188.67%
-2.55M
18.56%
-9.17M
259.22%
-7.15M
21.99%
-6.81M
4.77%
-3.02M
55.64%
-1.82M
39.61%
-1.54M
15.34%
free cash flow
-42.45M
-
-61.72M
45.40%
-79.61M
28.99%
-137.23M
72.38%
-172.85M
25.96%
-200.98M
16.27%
-131.73M
34.45%
-191.63M
45.47%
-206.38M
7.69%
-148.74M
27.93%
-60.33M
59.44%

All numbers in (except ratios and percentages)